World Health Organization

Slides:



Advertisements
Similar presentations
Resource requirements for reaching the treatment goals under PEPFAR XV International AIDS Conference Bangkok July 15, 2004 Owen Smith, Abt Associates Inc.
Advertisements

Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
UN Strategic Plan on HIV/AIDS Midterm Performance review (2001 – 2003) Monitoring and Evaluation Reference Group 29 July 2003.
GLAAS and SWA at the EC/EIB Brussels Seminar 6 July |1 | GLAAS & SWA The evidence and the action 6 July 2010 Peregrine Swann Senior Adviser
Elizabeth Lule Manager ACTafrica The World Banks response to HIV/AIDS in Africa: MAP High Level Dialogue on Maximizing Synergies between Health Systems.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
A Call to Action Children – The missing face of AIDS.
Group III: Demand Forecasting
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.
National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Global Measles and Rubella Strategic Plan
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,
World Health Organization Department of HIV/AIDS Estimates of ARV Treatment Needs
Expert consultation on TB/HIV research priorities, February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Taking Another Look at Condoms Patrick Friel Reproductive Health HIV/AIDS Consultancy 27 April 2006.
Working Together to Improve Global Health
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Elizabeth Lule Manager ACTafrica The World Bank’s Support to HIV/AIDS Programs in Africa.
Technical Advisory Group meeting, WHO/WPRO
Global Hepatitis C Guidelines 2014: recommendations for a public health approach Gottfried Hirnschall.
Global Fund – PEPFAR Coordination The Tanzania Example Dr. Fatma Mrisho Chairperson TACAIDS.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
Managing Risk and Overcoming Health Systems Bottlenecks in Haiti Emerging Lessons Jessica Faieta - Senior Country-Director, UNDP/Haiti & Dr Joelle Deas.
The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.
Total health ODA commitments, US$ Billions.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Using the levy in order to finance recurring expenditures : the case of the International Drug Purchase Facility-UNITAID Meeting of experts on the solidarity.
The Global Fund- structure, function and evolution February 18, 2008.
IAS Members Working Together for a Stronger Health Workforce IAS General Members and Policy Meeting Sydney, 24 th July 2007.
Translating the Vision Towards Universal Access Dr Zengani Chirwa.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM Presentation by Alvaro Bermejo and Andriy Klepikov at the Stakeholders Meeting.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
World Health Organization "3 by 5" Target Access to HIV/AIDS Medicines The 3x5 strategy WHO/EDM Technical Briefing Seminar.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
The HIV Response Where are we now?
20:20 Vision Making new and old money work better
Zimbabwe’s shift towards treat all: national country context
Selected events related to the treatment of AIDS
Expanding ARV treatment in developing countries: Issues and Prospects
22nd International AIDS Conference Amsterdam, 24 July 2018
Key issues in DOTS implementation
Access to HIV/AIDS Medicines The 3x5 strategy
Primary Health Care Improvement Global Stakeholder Meting, Geneva
Presentation transcript:

World Health Organization Treat 3 million by 2005 Naisiadet Mason HIV/AIDS Department, WHO, Geneva, Switzerland CCIH, May 2004 World Health Organization "3 by 5" Initiative http://www.who.int/3by5

World Health Organization What is the "3 by 5" Target? 40,000,000 are infected with HIV/AIDS worldwide 6,000,000 need treatment every year 3,000,000 die because they do not get it 400,000 people living with AIDS have access to treatment today Antiretroviral Therapy (ART) keeps people with HIV/AIDS alive and healthy. It is not a cure The Goal: Provide access to treatment for all The Target: Treat 3 million HIV sufferers by 2005 World Health Organization "3 by 5" Initiative http://www.who.int/3by5

High burden countries in need of ART, Nov 2003

Countries that have appealed for WHO Technical Assistance, Feb 2004 World Health Organization "3 by 5" Initiative http://www.who.int/3by5

Widening Gap of AIDS Treatment World Health Organization Yearly deaths as a factor of total in 1995 2.0 Source: Adapted from WHO/UNAIDS Statistics & HIV/AIDS Surveillance in Europe, End-year report 2001, No 66, CESES AIDS Deaths in Africa 1.5 1.0 AIDS Deaths in Western Europe 0.5 Introduction of Highly Active Antiretroviral Treatment (HAART) 0.0 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 World Health Organization "3 by 5" Initiative http://www.who.int/3by5

What ARVs Can Do

Pillars of the "3 by 5" Strategy World Health Organization Global leadership, strong partnership and advocacy Urgent, sustained country support Simplified treatment Effective supply of medicines and diagnostics Learn by doing World Health Organization "3 by 5" Initiative http://www.who.int/3by5

A Simple Two-Pronged Approach WHO Strategy to Support Global Efforts to Scale Up Treatment Country Driven Simplification World Health Organization "3 by 5" Initiative http://www.who.int/3by5

A Simple Two-Pronged Approach World Health Organization Country Driven Scale-up & treatment happens in country. It is country driven Governments are responsible for the care and treatment of their citizens, including the poor and marginalized Multiple actors are involved in ART and with scale-up WHO provides technical support to governments Focus on UNAIDS "three ones" approach One National Plan One Coordinating Body One Monitoring and Evaluation System World Health Organization "3 by 5" Initiative http://www.who.int/3by5

A Simple Two-Pronged Approach World Health Organization Simplification Fixed Dose Combination (FDC) drugs simplify drug regimen to just one pill twice a day WHO has established an AIDS Medicines and Diagnostics Service (AMDS) to help countries streamline procurement and supply AMDS links with the WHO Procurement, Quality and Sourcing Project (pre-qualification), assessing products and manufacturers, facilitating procurement World Health Organization "3 by 5" Initiative http://www.who.int/3by5

The AMDS in Focus A project of UNAIDS, WHO, UNICEF the World Bank and other partners Activities of the AMDS: Strategic information Stockpiles and pooled procurement Product selection Demand forecasting Market intelligence on sources, prices, raw materials Technical support for product selection, procurement, supply-management and local production Prequalification of ARVs and diagnostics

World Health Organization What is "3 by 5" Building On? Opportunities Increased global political commitment and resources Simplified treatment and testing Cheaper drugs and generic competition Build on lessons from developing and developed countries Use ART to strengthen health systems and accelerate prevention Partners Experience World Health Organization "3 by 5" Initiative http://www.who.int/3by5

World Health Organization What is "3 by 5" Building On? Opportunities Partners UN and international agencies, governments, donors, non-governmental organizations including faith based organizations, researchers, people living with HIV/AIDS, private sector, charitable foundations, and communities Experience World Health Organization "3 by 5" Initiative http://www.who.int/3by5

World Health Organization What is "3 by 5" Building On? Opportunities Partners Experience Lessons learned by WHO in dealing with SARS, Polio, TB will be applied in addressing the world's worst health crisis: HIV/AIDS Lessons learned from partners, e.g. MSF in Khayelitsha, Partners in Health in Haiti, MTCT in Burkina Faso and treatment programs in the private sector World Health Organization "3 by 5" Initiative http://www.who.int/3by5

Funding for Treatment Scale-up Budget requirements through to December 2005: Countries $5.5 billion to scale-up treatment to reach the target of 3 million people WHO $218 million for WHO technical assistance, 85% to be spent in country World Health Organization "3 by 5" Initiative http://www.who.int/3by5

Achievements to date & next steps Dec 1st 2003 - Launched "3 by 5" strategy and simplified treatment guidelines Feb-April 2004 - 42 WHO staff deployed to 26 countries to help draw up 4th round GFATM proposals and national AIDS plans May-July 2004 - Technical assistance to countries ready for immediate scale-up Aug-Dec 2004 - Continued technical assistance to countries

World Health Organization Key dates July 2003 - Access to ART for all made WHO/UNAIDS core policy Sept 2003 - HIV/AIDS declared Global Health Emergency, UN General Assembly Nov 2003 - First partners meeting on proposed Strategy Dec 2003 - WHO UNAIDS "3 by 5" strategy launched Feb-June 2004 - WHO Technical Assistance in countries for GFATM proposals and development of National AIDS scale up plans and roll out May 2004 - WHA to consolidate political commitment and action. Second partners meeting on Operational Planning July 2004 - Bangkok AIDS Conference – WHO Business plan and report World Health Organization "3 by 5" Initiative http://www.who.int/3by5

Milestones for December 2005 50 countries request WHO support 60 countries establish ARV target 60 countries develop national implementation plans 50 countries use AMDS 50 countries use WHO-based certification of competence $50 to $200 yearly cost of ARV treatment 20,000 service outlets providing VCT 10,000 service outlets providing ART 100,000 health providers and community treatment supporters 30,000 partnerships with treatment outlets and community groups

World Health Organization The Time to Act is Now “To deliver antiretroviral treatment to the millions who need it, we must change the way we think and change the way we act. “Business as usual will not work. Business as usual means watching thousands of people die every single day.” LEE Jong-wook, Director-General, WHO World Health Organization "3 by 5" Initiative http://www.who.int/3by5